Browse All Drug Development Market Research Reports
List of reports from Drug Development
Displaying 1 to 6 (of 6 records)
| Pages: « Last 1 |
|
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity
Sep 2012 | By - GBI Research
Pathways to Efficient Drug Development Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity
GBI Research, the leading business intelligence provider, has released its latest research report, Pathways to Efficient Drug Development Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity. The report examines the reasons why the...
|
$3500 |
|
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market
Sep 2012 | By - GBI Research
Accelerating Drugs to Market Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market
GBI Researchs new report, Accelerating Drugs to Market Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market, presents various tools and strategies which can accelerate a drug to the market. In this report, GBI...
|
$3500 |
|
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge
May 2012 | By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research, Patient Perspectives Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge. The report examines the role of patients in changing the research agenda and helping pharma companies to bring effective medicines that meet real unmet medical needs...
|
$3500 |
|
Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
Jul 2011 | By - GBI Research
GBI Research, leading business intelligence provider, has released its latest research report, Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure, which provides insights into major drug failures during 20052010. The 20 drugs included in the report belong to key pharmaceutical companies and were undergoing...
|
$3500 |
|
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development
Jul 2011 | By - GBI Research
GBI Research has released its latest report, Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development that provides key data, information and analysis of the major trends and issues affecting the clinical trial market in Argentina. The report provides a comprehensive insight of the reasons for outsourcing...
|
$3500 |
|
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs
Jun 2011 | By - GBI Research
GBI Research has released its latest report, Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs that provides key data, information and analysis of the major trends and developments in the drug devleopment business. The report provides a comprehensive insight into key technological...
|
$3500 |
Displaying 1 to 6 (of 6 records)
| Pages: « Last 1 |
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
